Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Efficacy, and Safety of Octafibrin vs Haemocomplettan P in Congenital Fibrinogen Deficiency
NCT01575756Phase 2Completed
- Sponsor
- Octapharma
- Start
- Jun 2013
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 2 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by Octapharma. Started Jun 2013; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT01575756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575756.